Delivering on MPTs: Addressing the needs, rising to the challenges and making the opportunities

Contraception

Volumn 88, Issue 3, 2013, Pages 321-325

  Malcolm, R Karl ^a   Fetherston, Susan M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; MICROBICIDE;

CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL TECHNOLOGY; MULTIPURPOSE PREVENTION TECHNOLOGY; NOTE;

ADMINISTRATION, INTRAVAGINAL; ANTI-INFECTIVE AGENTS; CONTRACEPTION; CONTRACEPTIVE AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; SEXUALLY TRANSMITTED DISEASES;

EID: 84883448628     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.06.009     Document Type: Note

References (33)

1. S. Singh, G. Sedgh, and R. Hussain Unintended pregnancy: worldwide levels, trends, and outcomes Stud Fam Plann 41 2010 241 250
2. Prevalence and incidence of selected sexually transmitted infections. Chlamydia, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis 2011 World Health Organization Geneva http://whqlibdoc.who.int/publications/2011/ 9789241502450-eng.pdf
3. Sexual and reproductive health and HIV/AIDS linkages: a framework for priority linkages 2005 World Health Organization, United Nations Population Fund, International Planned Parenthood Federation, Joint United Nations Programme on HIV/AIDS Geneva http://whqlibdoc.who.int/hq/2005/WHO-HIV-2005.05- eng.pdf
4. Singh S, Darroch JE. Adding it up: Costs and benefits of investing in family planning and maternal and newborn health. Guttmacher Institute and United Nations Population Fund (UNFPA), 2011. http://www.guttmacher.org/pubs/ AIU-2012-estimates.pdf.
5. A. Rompalo Preventing sexually transmitted infections: back to basics J Clin Invest 121 2011 4580 4583
6. P.F. Harrison, A. Hemmerling, J. Romano, K.J. Whaley, and B. Young Holt Developing multipurpose reproductive health technologies: an integrated strategy AIDS Res Treat 2013 [Article ID 790154]
7. United Nations Development Programme. The Millennium Development Goals. http://www.undp.org/mdg. [Last accessed 4 March 2013.].
8. L. Warner, M.F. Gallo, and M. Macaluso Condom use around the globe: how can we fulfil the prevention potential of male condoms? Sex Health 9 2012 4 9
9. R. Ingham Condoms, bloody condoms: yet more problems Sex Transm Infect 88 2012 479 480
10. Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012;4:151ra125.
11. J.M. Baeten, D. Donnell, and P. Ndase Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 2012 399 410
12. J. Kenney, A. Aravantinou Meropi, and R. Singer An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques PLoS One 6 1 2001 e15835
13. R.G. Frezieres, T. Walsha, and M. Kilbourne-Brook Couples' acceptability of the SILCS diaphragm for microbicide delivery Contraception 85 2012 99 107
14. P.J. Feldblum, A. Adeiga, and R. Bakare SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria PLoS One 3 2008 e1474 10.1371/journal.pone.0001474
15. S. McCormack, G. Ramjee, and A. Kamali PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial Lancet 376 2010 1329 1337
16. L. Peterson, K. Nanda, and B.K. Opoku SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana PLoS One 2 2007 e1312 10.1371/journal.pone.0001312
17. S. Skoler-Karpoff, G. Ramjee, and K. Ahmed Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1977 1987
18. L. Van Damme, G. Ramjee, and M. Alary Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial Lancet 360 2002 971 977
19. S.S. Abdool Karim, A.D.M. Kashuba, and L. Werner Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women Lancet 378 2011 279 281
20. Microbicide Trails Network MTN statement on decision to discontinue use of Tenofovir Gel in VOICE, a major HIV prevention study in women http://www.mtnstopshiv.org/node/3909
21. R.K. Malcolm, A.D. Woolfson, and C.F. Toner Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings J Antimicrob Chemother 56 2005 954 956
22. A. Nel, S. Smythe, and K. Young Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women J Acquir Immune Defic Syndr 51 2009 416 423
23. M. Elstein, R. Jackson, D. Hickling, and R. Assendorp Current status of contraceptive vaginal rings [Article in French] Contracept Fertil Sex (Paris) 20 1992 15 19
24. W. Bounds, A. Szarewski, D. Lowe, and J. Guillebaud Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring Eur J Obstet Gynecol Reprod Biol 48 1993 123 125
25. I.S. Fraser, M. Lacarra, and D.R. Mishell Vaginal epithelial surface appearances in women using vaginal rings for contraception Contraception 61 2000 131 138
26. E. Weisberg, I.S. Fraser, and J. Baker A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring Contraception 62 2000 83 89
27. S.B. Mostad, J. Overbaugh, and D.M. DeVange Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina Lancet 350 1997 922 927
28. R. Heffron, D. Donnell, and H. Rees Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study Lancet Infect Dis 12 2012 19 26
29. M. Kiddugavu, F. Makumbi, and M.J. Wawer Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda AIDS 17 2003 233 240
30. V. Brache, R. Sitruk-Ware, and A. Williams Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women Contraception 85 2012 480 488
31. V. Brache, D.R. Mishell, and P. Lahteenmaki Ovarian function during use of vaginal rings delivering three different doses of NES Contraception 63 2001 257 261
32. I. Major, P. Boyd, M. Kilbourne-Brook, G. Saxon, J. Cohen, and R.K. Malcolm A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine Contraception 88 1 2013 58 66
33. C. Ball, E. Krogstad, T. Chaowanachan, and K.A. Woodrow Drug-eluting fibers for HIV-1 inhibition and contraception PLoS One 7 11 2012 e49792